Note on Valuing a Biotech Company Note on Valuing a Biotech Company

Note on Valuing a Biotech Company

9B08N005

James E. Hatch
    • £1.99
    • £1.99

Publisher Description

This technical note discusses the methods and factors that investment bankers and venture capitalists take into account when placing a value on the shares of biotech companies.

GENRE
Business & Personal Finance
RELEASED
2008
11 March
LANGUAGE
EN
English
LENGTH
12
Pages
PUBLISHER
Richard Ivey School of Business Foundation
SIZE
408.1
KB

More Books Like This

Financial Times Guide to Corporate Valuation, The Financial Times Guide to Corporate Valuation, The
Financial Times Guide to Corporate Valuation, The
2012
Note on Valuation for Venture Capital Note on Valuation for Venture Capital
Note on Valuation for Venture Capital
2009
Security Analysis and Business Valuation on Wall Street Security Analysis and Business Valuation on Wall Street
Security Analysis and Business Valuation on Wall Street
2010
Value Value
Value
2010
Raising Venture Capital for the Serious Entrepreneur Raising Venture Capital for the Serious Entrepreneur
Raising Venture Capital for the Serious Entrepreneur
2007
Valuation Valuation
Valuation
2020

More Books by James E. Hatch

Note on Private Company Valuation Note on Private Company Valuation
Note on Private Company Valuation
2001
North Village Capital Private Equity North Village Capital Private Equity
North Village Capital Private Equity
2010
Lululemon Athletica: Pitching an IPO Lululemon Athletica: Pitching an IPO
Lululemon Athletica: Pitching an IPO
2011
Valuing Wal-Mart 2010 Valuing Wal-Mart 2010
Valuing Wal-Mart 2010
2011
Note on Legal Aspects of Secured Lending in Canada Note on Legal Aspects of Secured Lending in Canada
Note on Legal Aspects of Secured Lending in Canada
2011
Note on Contents of a Term Sheet Note on Contents of a Term Sheet
Note on Contents of a Term Sheet
2002